Garren Hideki 4
4 · PROTHENA CORP PUBLIC LTD CO · Filed Jun 16, 2023
Insider Transaction Report
Form 4
Garren Hideki
Chief Medical Officer
Transactions
- Exercise/Conversion
Ordinary Shares, par value $0.01 per share
2023-06-16$24.90/sh+7,331$182,542→ 7,331 total - Sale
Ordinary Shares, par value $0.01 per share
2023-06-16$74.00/sh−7,331$542,494→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-06-16−7,331→ 198,000 totalExercise: $24.90Exp: 2031-04-05→ Ordinary Shares (7,331 underlying)
Footnotes (2)
- [F1]The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023.
- [F2]The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on April 5, 2022, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.